MERCK & CO. INC. (1MRKX.MI) Stock Price & Overview

BIT:1MRKX • US58933Y1055

103.2 EUR
+13 (+14.41%)
Last: Feb 5, 2026, 07:00 PM

The current stock price of 1MRKX.MI is 103.2 EUR. Today 1MRKX.MI is up by 14.41%. In the past month the price increased by 49.35%.

1MRKX.MI Key Statistics

1-Month Range66.6 - 103
Current 1MRKX.MI stock price positioned within its 1-month range.
Market Cap
256.144B
P/E
13.33
Fwd P/E
22.63
EPS (TTM)
7.74
Dividend Yield
2.85%

1MRKX.MI Stock Performance

Today
+14.41%
1 Week
+16.74%
1 Month
+49.35%
3 Months
+50.88%
Longer-term
6 Months N/A
1 Year N/A
2 Years N/A
3 Years N/A
5 Years N/A
10 Years N/A

1MRKX.MI Stock Chart

MERCK & CO. INC. / 1MRKX Daily stock chart

1MRKX.MI Technical Analysis

ChartMill assigns a technical rating of 6 / 10 to 1MRKX.MI.


Chartmill TA Rating
Chartmill Setup Rating
1MRKX.MI Full Technical Analysis Report

1MRKX.MI Fundamental Analysis

ChartMill assigns a fundamental rating of 6 / 10 to 1MRKX.MI. 1MRKX.MI has an excellent profitability rating, but there are some minor concerns on its financial health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
1MRKX.MI Full Fundamental Analysis Report

1MRKX.MI Earnings

On February 3, 2026 1MRKX.MI reported an EPS of 2.09 and a revenue of 16.40B. The company beat EPS expectations (2.98% surprise) and beat revenue expectations (0.31% surprise).

Next Earnings DateApr 30, 2026
Last Earnings DateFeb 3, 2026
PeriodQ4 / 2025
EPS Reported$2.09
Revenue Reported16.4B
EPS Surprise 2.98%
Revenue Surprise 0.31%
1MRKX.MI Earnings History

1MRKX.MI Forecast & Estimates

34 analysts have analysed 1MRKX.MI and the average price target is 99.7 EUR. This implies a price decrease of -3.39% is expected in the next year compared to the current price of 103.2.

For the next year, analysts expect an EPS growth of -41.06% and a revenue growth 4.34% for 1MRKX.MI


Analysts
Analysts77.06
Price Target99.7 (-3.39%)
EPS Next Y-41.06%
Revenue Next Year4.34%
1MRKX.MI Forecast & Estimates

1MRKX.MI Groups

Sector & Classification

Sub-Industry
Pharmaceuticals
Index Membership

1MRKX.MI Financial Highlights

Over the last trailing twelve months 1MRKX.MI reported a non-GAAP Earnings per Share(EPS) of 7.74. The EPS increased by 20.16% compared to the year before.


Income Statements
Revenue(TTM)65.01B
Net Income(TTM)19.03B
Industry RankSector Rank
PM (TTM) 29.63%
ROA 14.69%
ROE 36.71%
Debt/Equity 0.77
Chartmill High Growth Momentum
EPS Q2Q%21.51%
Sales Q2Q%4.97%
EPS 1Y (TTM)20.16%
Revenue 1Y (TTM)1.31%
1MRKX.MI financials

1MRKX.MI Ownership

Ownership
Inst Owners80.32%
Shares2.48B
Float2.48B
Ins Owners0.05%
Short Float %N/A
Short RatioN/A
1MRKX.MI Ownership

1MRKX.MI Competitors/Peers

The largest stocks on the EU markets in the "Pharmaceuticals" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
SAN SANOFI9.04187.74B
SNW SANOFI9.04187.692B
1SAN SANOFI9.02187.378B
UNC UCB SA24.3851.176B
UCB UCB SA24.4150.164B
MRK MERCK KGAA12.8149.217B
BAYN BAYER AG-REG7.4537.111B
1BAYN BAYER AG-REG7.6536.973B
IPN IPSEN14.1113.795B
TUB FINANCIERE DE TUBIZE N/A10.059B
REC RECORDATI INDUSTRIA CHIMICA16.159.95B
VIRP VIRBAC SA16.32.907B
DMP DERMAPHARM HOLDING SE15.262.062B

About 1MRKX.MI

Company Profile

1MRKX logo image Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. The company is headquartered in Rahway, New Jersey and currently employs 75,000 full-time employees. Its Pharmaceutical segment includes human health pharmaceutical and vaccine products. The firm sells its human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers. The company sells these human health vaccines primarily to physicians, wholesalers, distributors and government entities. Its Animal Health segment discovers, develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all livestock and companion animal species. Its products include KEYTRUDA (pembrolizumab) injection, for intravenous use; WELIREG (belzutifan) tablets, for oral use; Ohtuvayre (ensifentrine) and others.

Company Info

MERCK & CO. INC.

126 East Lincoln Avenue, P.O. Box 2000

Rahway NEW JERSEY US

Employees: 75000

1MRKX Company Website

1MRKX Investor Relations

Phone: 19087404000

MERCK & CO. INC. / 1MRKX.MI FAQ

What does MERCK & CO. INC. do?

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. The company is headquartered in Rahway, New Jersey and currently employs 75,000 full-time employees. Its Pharmaceutical segment includes human health pharmaceutical and vaccine products. The firm sells its human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers. The company sells these human health vaccines primarily to physicians, wholesalers, distributors and government entities. Its Animal Health segment discovers, develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all livestock and companion animal species. Its products include KEYTRUDA (pembrolizumab) injection, for intravenous use; WELIREG (belzutifan) tablets, for oral use; Ohtuvayre (ensifentrine) and others.


Can you provide the latest stock price for MERCK & CO. INC.?

The current stock price of 1MRKX.MI is 103.2 EUR. The price increased by 14.41% in the last trading session.


Does 1MRKX stock pay dividends?

MERCK & CO. INC. (1MRKX.MI) has a dividend yield of 2.85%. The yearly dividend amount is currently 2.61.


How is the ChartMill rating for MERCK & CO. INC.?

1MRKX.MI has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 6 out of 10.


How is the market expecting 1MRKX stock to perform?

34 analysts have analysed 1MRKX.MI and the average price target is 99.7 EUR. This implies a price decrease of -3.39% is expected in the next year compared to the current price of 103.2.


What is MERCK & CO. INC. worth?

MERCK & CO. INC. (1MRKX.MI) has a market capitalization of 256.14B EUR. This makes 1MRKX.MI a Mega Cap stock.